| Literature DB >> 29326649 |
Stefan Kammermeier1, Lucia Dietrich1,2, Kathrin Maierbeck1,3, Annika Plate1, Stefan Lorenzl1,4, Arun Singh1,5, Kai Bötzel1.
Abstract
Progressive supranuclear palsy (PSP) and late-stage idiopathic Parkinson's disease (IPD) are neurodegenerative movement disorders resulting in different postural instability and falling symptoms. IPD falls occur usually forward in late stage, whereas PSP falls happen in early stages, mostly backward, unprovoked, and with high morbidity. Postural responses to sensory anteroposterior tilt illusion by bilateral dorsal neck vibration were probed in both groups versus healthy controls on a static recording posture platform. Three distinct anteroposterior body mass excursion peaks (P1-P3) were observed. 18 IPD subjects exhibited well-known excessive response amplitudes, whereas 21 PSP subjects' responses remained unaltered to 22 control subjects. Neither IPD nor PSP showed response latency deficits, despite brainstem degeneration especially in PSP. The observed response patterns suggest that PSP brainstem pathology might spare the involved proprioceptive pathways and implies viability of neck vibration for possible biofeedback and augmentation therapy in PSP postural instability.Entities:
Keywords: falling; idiopathic Parkinson’s disease; neck vibration; posture; posturography; progressive supranuclear palsy
Year: 2017 PMID: 29326649 PMCID: PMC5742483 DOI: 10.3389/fneur.2017.00689
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Clinical parameters of participants in this study.
| (A) | ||||
|---|---|---|---|---|
| CTR | Sex | Age | Height | Weight |
| 1 | 0 | 58 | 159 | 54 |
| 2 | 1 | 60 | 173 | 70 |
| 3 | 0 | 51 | 179 | 73 |
| 4 | 1 | 60 | 163 | 66 |
| 5 | 0 | 60 | 154 | 60 |
| 6 | 0 | 67 | 168 | 64 |
| 7 | 0 | 57 | 168 | 63 |
| 8 | 1 | 62 | 180 | 78 |
| 9 | 1 | 46 | 168 | 105 |
| 10 | 0 | 40 | 167 | 90 |
| 11 | 0 | 73 | 155 | 57 |
| 12 | 0 | 61 | 168 | 57 |
| 13 | 1 | 60 | 174 | 81 |
| 14 | 0 | 56 | 159 | 65 |
| 15 | 0 | 60 | 171 | 88 |
| 16 | 0 | 70 | 165 | 72 |
| 17 | 1 | 69 | 176 | 100 |
| 18 | 1 | 60 | 185 | 100 |
| 19 | 0 | 60 | 176 | 81 |
| 20 | 1 | 67 | 180 | 103 |
| 21 | 1 | 42 | 183 | 95 |
| 22 | 1 | 61 | 183 | 115 |
| Median ± SD | 60 ± 8.4 | 170 ± 9.1 | 76 ± 18.1 | |
Controls subjects (CTR), idiopathic Parkinson’s disease (IPD), and progressive supranuclear palsy (PSP) are shown with sex (0 female and 1 male) (values are represented as median ± SD), age, height in centimeter, weight in kilogram, disease duration (years diagnosed with disease in IPD and months in PSP), and clinical scores Unified Parkinson Disease Rating Score (UPDRS) with items I, II, III and modified III (scaled each question/task 0–4), postural instability and gait difficulty (PIGD), and Hoehn & Yahr Scale (H&Y) along with 0–4 rated items extremity and axial rigidity; for PSP, apply specifically: Berg Balance Scale (BBS), Golbe Score, PSP staging scale, the scale of the NNiPPS study (Neuroprotection and Natural History in Parkinson Plus syndromes), frontal assessment battery (FAB), Mini-Mental State Examination (MMSE), PSP rating scale (PSPRS), Schwab & England activities of daily living (SEADL), and Montgomery-Åsberg depression rating scale (MADRS). Whether patients received rasagiline as participants in the PROSPERA study is indicated by in the column “Verum” (1 = yes). PSP patients who had levodopa in their medication regimen are indicated with “1” in the respective section; all IPD patients received levodopa. In the given collective, there was no significant effect of clinical parameters on performance in vibration effects or for Rasagiline within the PSP group.
Figure 1Illustrates the response pattern to neck vibration in idiopathic Parkinson’s disease (IPD), progressive supranuclear palsy (PSP), and healthy controls over a scale of 1 s before to 3 s after stimulus onset in pooled data (“grand average”); body excursions measured by center of foot pressure (COP) are scaled in centimeters in the body’s sagittal plane (anteroposterior motion) as a surrogate parameter for center of mass (COM). The upper portion (A) depicts the eyes open (EO) condition, and the eyes closed (EC) condition is shown in the lower graph (B). Peaks are designated P1, P2, and P3 in the range of 400–1,400 ms after stimulus onset.
Figure 2(A,B,C) The mean amplitudes of anteroposterior center of foot pressure (COP) displacement of peaks P1, P2, and P3, respectively, as defined in Figure 1. Amplitudes for the eyes open (EO) and eyes closed (EC) conditions are shown, which differed within-group significantly for all groups. IPD subjects exhibited larger peak amplitudes compared to control subjects across P1–P3. PSP did not exhibit differences to controls or IPD other than for P2, taking a middle ground. P2 was significantly lower for PSP than IPD. Detailed analysis is given in Table 2.
Statistical analysis of group effects with degrees of freedom for group affiliation (controls CTR, IPD, and PSP) and visual condition [eyes open (EO) or eyes closed (EC)] across peaks P1 through P3.
| Peak analysis | Effect of EO versus EC Greenhouse–Geisser | Effect of group affiliation Greenhouse–Geisser | Effect of Eyes × groups interaction Greenhouse–Geisser | ||
|---|---|---|---|---|---|
| Group pairs | |||||
| Peak 1 | Control-IPS | ||||
| Control-PSP | |||||
| IPS-PSP | |||||
| Peak 2 | Control-IPS | ||||
| Control-PSP | |||||
| IPS-PSP | |||||
| Peak 3 | Control-IPS | ||||
| Control-PSP | |||||
| IPS-PSP | |||||
Idiopathic Parkinson’s disease (IPD) presented consistently higher peaks than controls with progressive supranuclear palsy (PSP) taking a middle ground between without significant differences to either group. Only for Peak 2, IPD amplitude was distinct from both other groups. Analysis was performed using repeated measures ANOVA with Mauchley’s Sphericity test and Greenhouse-Geisser correction.